th day after the transplantation in allogeneic non-immunosuppressed rats. Biopsies embedded with historesin were taken from the flap and normal contralateral skin (used as control) on the 3 rd , 7 th , 15 th , and 30 th days after the surgery. A quantitative study of infiltrating lymphocytes in the flaps, with and without cyclosporin A, was done by evaluating the local inflammatory infiltrate. A significant increase in the number of lymphocytes among the rejection and immunosuppressed groups was seen, as compared to the isogenic set. Local lymphocytosis in allogeneic non-immunosuppressed transplantations reached its highest level on the 3 rd day after surgery, before gross findings of rejection, which could only be seen by naked eye on the 5 th or 6 th day. Therefore, we conclude that cyclosporin A is effective in preserving allogenic transplantation in rats. Biopsies of transplanted areas may contribute to earlier diagnosis of the need for immunosuppressive therapy.
SUMMARY: The rejection of allotransplantation of epigastric microsurgical flaps and the effect of immunosuppression have been studied in 58 rats. Three sets of experiments were planned: (1) Wistar Furth isogenic donors and receptors (control set); (2) Brown Norway donors and Wistar Furth receptors (rejection set); and (3) Brown Norway donors and Wistar Furth immunosuppressed receptors (cyclosporin A set). Cyclosporin A (10 mg/kg/d) treated rats had a transplantation survival rate of up to 30 days: 83.3% among isogenic animals and 60% among allogeneic. There was 100% rejection by the 9 th day after the transplantation in allogeneic non-immunosuppressed rats. Biopsies embedded with historesin were taken from the flap and normal contralateral skin (used as control) on the 3 rd , 7 th , 15 th , and 30 th days after the surgery. A quantitative study of infiltrating lymphocytes in the flaps, with and without cyclosporin A, was done by evaluating the local inflammatory infiltrate. A significant increase in the number of lymphocytes among the rejection and immunosuppressed groups was seen, as compared to the isogenic set. Local lymphocytosis in allogeneic non-immunosuppressed transplantations reached its highest level on the 3 rd day after surgery, before gross findings of rejection, which could only be seen by naked eye on the 5 th or 6 th day. Therefore, we conclude that cyclosporin A is effective in preserving allogenic transplantation in rats. Biopsies of transplanted areas may contribute to earlier diagnosis of the need for immunosuppressive therapy.
DESCRIPTORS: Allotransplantation. Cyclosporin A.
Organs and tissue transplantations have always been one of the alternatives suggested for the correction of congenital acquired diseases 16, 30 . However, tissues coming from autogenous donor areas are relatively scarce.
Thus, there are clinical circumstances in which it would be desirable to obtain tissues from donors (alive or dead), as in very large burned areas 1, 7, 8 , complex oncologic or traumatic tissue loss, and limb reconstruction due to trauma or aplasia 11, 32 . The improvement of skin graft survival with the use of cyclosporin A has already been proved 1, 2, 12, 15, 19 . However, attempts at achieving full integration of skin grafts have not always been successful 1, 9, 17, 21, 23, 34 .
The use of immunosuppressing drugs, usually accompanied by the concurrent adverse side effects, has fewer restrictions with organ transplantations that are essential to the patient's survival. Limb and tissue transplantations, however, have more restraints 20 . Therefore, allogeneic transplantations of tissues and limbs 27 , despite their technical feasibility, have not been done in humans, and research has been limited 32 . In order to contribute to the study of rejection of cutaneous allotransplantations with and without the use of cyclosporin A, we developed an experimental model. Survival indexes and lymphocyte quantitative studies were performed. A detailed description of gross changes of the skin was recorded during the 30 days following surgery. On the third day after surgery, a microscopic review of the anastomoses was performed.
MATERIAL AND METHOD

Fifty
Biopsy specimens of the flap of the contralateral skin (control) were obtained from groups I and Ci on the 3 rd , 7
th , 15 th , and 30 th days after the surgery, and from R group on the 3 rd and 7 th postoperative days. The specimens were prepared in methacrylate historesin and stained with toluidine blue, and are labelled as follows: ICo = control skin from the isogenic group; IT = isogenic group transplantation; RCo = control skin from the rejection group; RT = rejection group transplantation; CiCo = control skin from the cyclosporin group; CiT = cyclosporin group transplantation.
The postoperative day when the biopsies were taken was added to the code.
A double-blind study was performed for lymphocyte quantitation in the tissue. Lymphocyte quantitation was performed through comparison of means obtained in 18 fields. A graticule adapted to the ocular (10x) with 50 randomly distributed lines was used, and lymphocytes that were intersected by the lines were counted. Due to the great individual variations, a non-parametric statistical analysis was performed with a Mann-WhitneyWilcoxon test 37 . Statistical significance was declared at p < 0.05.
RESULTS
Among the 58 animals that underwent transplantation, 45 (77.6%) presented pervious anastomoses when evaluated on the 3 rd postoperative day. Thirteen animals (22.4%) presented thrombosis in artery, vein, or both near the anastomoses, and therefore these individuals were excluded from the study. Among the 45 remaining rats, 30 survived to the end of the 30 day follow-up period (12 from I, 8 from R and 10 from Ci group) (Table 1) .
Daily microscopic analysis of the flaps from I group showed moderate edema, although color and hair development remained similar to the adjacent skin area that had not undergone surgery, other than local moderate edema.
On the 1st and 2nd postoperative days, Group R transplantations resembled those of group I. Subsequently, local edema was much more intense, and on the 4 th or 5 th day, hyperemia and local signs of tissue involvement were evident, which evolved from local ulceration and necrosis to full necrosis between the 6th and 9th days.
Among the 10 rats from the Ci group, 60% of the flaps survived. Four (40%) presented total necrosis at different times, observed on the 10 th , 18 th , 19 th , and 24 th postoperative days (Table  1) . These animals showed an intense early edema after surgery (3 rd and 4 th days after surgery). Gross examination of rats with 30-day graft survival showed significant differences between the three studies sets, group I= 83,3%, group R = 0 and group Ci = 60%. There was a significant difference in the histologic analysis of normal skin and flap biopsies in all postoperative days for groups R and Ci, and only on the 15 th day for I group. Lymphocytes in control skin among the 3 groups were scarce or absent in all studied postoperative days.
We have compared counting of lymphocytes among the different groups for each studied postoperative day. There were statistically significant differences between of groups I and R on the 3 rd postoperative day (Table 2) , and between the controls of I and Ci groups on the 7 th day (Table 3) .
DISCUSSION
The feasibility of a future use of allogeneic 60% tissue and limb transplantations in reconstructive plastic surgery 11, 14 justifies the development of an experimental model for the systematic study of skin rejection.
A 77.6% vascular permeability was obtained-a satisfactory rate, according to the literature, in which 75 to 90% permeability has been seen 26, 28, 29, 33 . The isogenic flap survival rate, 83.3%, was considered the basal line for evaluation of the other sets of experiments.
Mortality, although high (33.3%), occurred in different postoperative phases before we observed any gross sign of rejection. Therefore, we were able to evaluate transplantation for 30 days among the remaining 30 animals without having to consider mortality as a variant for the rejection factor.
In group R, flap loss occurred in 100% of the cases after 6 to 8 days, a rate which is significantly different from group I (Table 1) . Gross findings for group R clearly characterized a rejection delay occurring according to the reported literature 22, 31 . However, rejection occurred earlier than the ones observed in organ transplantations, such as heart 4, 13, 18 , kidney 25, 35, 36 , and small bowel rejection in rats 24 . Similarly in the Ci group, rejection occurred earlier than for other tissues and organs, even with the use of cyclosporin A 22 . A higher skin antigenicity may be the reason why flaps are rejected earlier than other tissues, although the mechanism is not yet fully understood 5, 6, 10 . A 30-day follow-up survival was observed in six flaps from Ci Group. Four flap losses occurred on the 10th, , and 23rd postoperative days. Therefore cyclosporin A was effective, increasing survival rates of cutaneous allogeneic transplantations.
Third day post-op biopsy lymphocyte counts had significant differences between the allogenic non-treated transplantation group (R) and isogenic transplantation group (I) ( Table 2) .
Comparison between gross rejection findings and lymphocytic infiltration showed that lymphocyte infiltration precedes gross signs of necrosis. The lymphocyte infiltration occurred on the 3 rd day post operative, whereas symptoms of gross rejection were first seen on the 6 th post-operative day. Therefore, as reported in the literature, biopsy specimens must be taken and examined for early signs of rejection in order to prevent full necrosis of the transplanted tissue.
In group Ci, there was a significant difference in lymphocytes counted between transplanted and control sets. Thus, it was observed that even though cyclosporin A had a satisfactory action on rejection control, its use did not result in a decrease in the number of "in situ" lymphocytes with the method used.
Based on what was found, the authors continued researching immunohistochemical methods with monoclonal antibodies 3, 6, 22 to identify the "in situ" lymphocytes found in this experimental model.
CONCLUSION
1) The rate of survival of epigastric flap used as microsurgical cutaneous transplantation to isogenic Wistar Furth rats was 83.3% up to 30 days, confirming the efficacy of the adopted experimental model.
2) In our experiments, when flaps of Brown-Norway rats are transplanted to Wistar-Furth receptors, a 100% rejection rate in non-immunosuppressed transplantation occurs before the 9 th postoperative day.
3) Cyclosporin A immunosuppression (10 mg/kg/d) increased the allogeneic transplantation success up to 30 days post-operation.
4) Non-immunosuppressed allotransplantation shows a significant increase of infiltrating lymphocytes on the 3 rd day as compared to isogenic transplantation. Symptoms of gross rejection findings are preceded by lymphocytic infiltration.
5) Despite the use of cyclosporin A, an increased rate in the lymphocytic infiltration was seen, as compared to the control isogenic transplantation group. Therefore, it may be assumed that cyclosporin A induces rejection delay, blocking the cytotoxic cell effect or humoral immune reaction, even though cell migration does occur.
6) The use of plastic embedded tissue enables a better characterization of the histological findings of rejection.
Further studies with immunohistochemical cell sorting are ongoing in our laboratories to enhance our knowledge in this field. 
